External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population

Natalie Terzikhan, Albert Hofman, Jaap Goudsmit, Mohammad Arfan Ikram*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
19 Downloads (Pure)

Fingerprint

Dive into the research topics of 'External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population'. Together they form a unique fingerprint.

Mathematics